Biktarvy, formally known as bictegravir, includes a powerful single-tablet regimen for treating HIV infection. This formula unites three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the virus's ability to multiply within the body, considerably decreasing the viral load. For many individual